You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.
Helping Labs with Cash Flow, COVID-19 Response - The Dark Intelligence Group

Helping Labs with Cash Flow, COVID-19 Response

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

ROUTINE SPECIMEN VOLUME REMAINS DOWN by 50% or more for clinical laboratories and anatomic pathology groups in the United States because of the pandemic. Through the end of last week, The Dark Report estimates that labs in the U.S. have lost almost $7 billion since the first week of March.

That’s when patients stopped visiting their doctors and hospitals ceased admitting patients for elective services. This is a financial disaster without precedent in modern medicine and the clinical laboratory industry. Many labs and pathology groups may not survive much past the end of the SARS-CoV-2 outbreak. Over the past eight weeks, The Dark Report has been in the forefront of documenting these developments and guiding pathologists and clinical lab administrators on effective strategies, winning responses, and opportunities to deliver more value to the hospitals, physicians, and patients they serve daily with vital lab testing services.

But we are ready to do even more for you and your lab team! Today, we launched COVID-19 STAT Intelligence Briefings at the URL: https://covid19briefings.com. This is a free service, which will deliver to you daily information that is actionable and that you can use immediately to keep your lab or pathology group at the front edge of COVID-19 testing services in a financially-sustainable manner. You’ll get timely intelligence in these four areas:

1) Metrics on key aspects of rapid molecular testing and serological testing for COVID-19 (including rates of positive and negative test results), presented in dashboards provided by leading companies in lab billing/collections, lab analytics, and lab-specific CRMs.

2) Proven steps for labs to introduce and validate COVID-19 tests, (both rapid molecular tests and serological tests) and have confidence that the results are accurate, reproducible, and high quality.

3) Latest developments on getting paid for COVID-19 testing to ensure every lab’s financial stability and clinical quality.

4) Legal and regulatory updates for labs doing COVID-19 tests to ensure full compliance.

For 26 years, we’ve worked hard to provide you with valuable management insights that improve patient care and bolster your lab’s financial performance. In this crisis, count on us to go the extra mile on your behalf!

Comments

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.